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Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized 
by persistent emotional, mental, and physical fatigue accompanied by a range of neurological, 
autonomic, neuroendocrine, immune, and sleep problems. Research has shown that psychosocial 
factors such as anxiety and depression as well as the symptoms of the illness, have a significant 
impact on the quality of life of people with ME/CFS. In addition, individuals may suffer from 
deficits in memory and concentration. This study set out to explore the relationships between 
variables which have been found to contribute to cognitive performance, as measured by pro-
spective and retrospective memory, and cognitive failures.
Methods: Eighty-seven people with ME/CFS answered questionnaires measuring fatigue, 
depression, anxiety, social support, and general self-efficacy. These were used in a correlational 
design (multiple regression) to predict cognitive function (self-ratings on prospective and ret-
rospective memory), and cognitive failures.
Results: Our study found that fatigue, depression, and general self-efficacy were directly associ-
ated with cognitive failures and retrospective (but not prospective) memory.
Conclusion: Although it was not possible in this study to determine the cause of the deficits, 
the literature in this area leads us to suggest that although the pathophysiological mechanisms 
of ME/CFS are unclear, abnormalities in the immune system, including proinflammatory 
cytokines, can lead to significant impairments in cognition. We suggest that fatigue and 
depression may be a result of the neurobiological effects of ME/CFS and in addition, that 
the neurobiological effects of the illness may give rise to both fatigue and cognitive deficits 
independently.
Keywords: myalgic encephalomyelitis/chronic fatigue syndrome, memory, cognitive deficits, 
depression
Introduction
Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), is 
a condition of unknown etiology, which is highly heterogeneous and has had a con-
troversial history producing conflicting findings not only relating to its cause, but also 
with regard to its course and prognosis.1 ME/CFS is characterized by persistent mental 
and physical fatigue accompanied by a range of neurological, autonomic, neuroendo-
crine, immune, and sleep problems.2 Epidemiological studies have shown prevalence 
rates of ME/CFS to be as low as three and as high as 2,800 per 100,000.1 ME/CFS is 
a highly intrusive illness that impacts on an individual’s personal, social, occupational, 
and recreational life3 and has significant costs for wider society.4 The present study 
aims to explore the association between a number of different variables (self-efficacy, 
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social support, anxiety, depression, and fatigue) and cognitive 
performance, as cognitive dysfunction is also a key issue in 
the illness experience of those with ME/CFS, often affecting 
quality of life.2
Fatigue is central to the definition, and experience, of 
ME/CFS. However, fatigue is not a unitary concept and can 
be defined in a number of ways. A distinction can be made 
between peripheral fatigue (characterized by failure to sustain 
the force of muscle contraction) and central fatigue (a feeling 
of constant exhaustion is an aspect of this type of fatigue).5 
Researchers make a distinction between mental, or cognitive 
fatigue, and physical or muscle fatigue.6,7  Chaudhuri and 
Behan5 state that mental fatigue is an important cognitive 
component of central fatigue.
The link between fatigue and cognitive function has been 
reported in patients with HIV8 and chronic pain.9 In the lat-
ter context, it is noteworthy that chronic widespread pain 
and fibromyalgia are frequent in ME/CFS. Furthermore, it 
has been reported that up to 80% of patients with ME/CFS 
have problems with memory and concentration.10 However, 
the evidence for objectively observable deficits in cognitive 
measures is inconsistent.11 Wearden and Appleby12 reported 
that despite patients reporting cognitive deficits, many stud-
ies that compare the performance of ME/CFS patients with 
healthy controls show no significant difference in tests of 
memory. This was supported by research by DiClementi 
et al,13 who found that there was no significant difference 
between patients with ME/CFS and controls on global tests 
of memory. Conversely, Sandman et al14 showed that patients 
with ME/CFS performed significantly worse than both 
depressed patients and healthy controls on recall tests and 
overrated their abilities despite having normal neuropsycho-
logical profiles. Finally, in a large study of people diagnosed 
with ME/CFS (N=307), where an extensive battery of tests 
had been administered, Thomas and Smith15 demonstrated 
clear cognitive  impairment which occurred independently 
of psychopathology.
There are of course different measures of memory 
which have been tested in people with chronic illness. Most 
cognitive research has focused on retrospective memory;16 
eg, remembering words or events that were experienced 
or occurred in the past. However, of greater importance in 
the daily lives of people with chronic illness is prospec-
tive memory, which has been defined as “remembering to 
carry out intended actions at an appropriate point in the 
future.”17 Three types of prospective memory task have 
been identified, which are based on differences in their 
contextual retrieval demands: these are event-, time-, and 
activity-based.18 Time-based prospective memory tasks are 
dependent on self-initiated monitoring, as they involve doing 
something at a predesignated time, such as remembering to 
take  medication. Event-based prospective memory tasks are 
cued by an external situation, such as remembering to pass 
on a message when seeing a friend. In contrast, activity-
based intentions are associated with carrying out a specific 
task before or after another activity, such as remembering 
to turn off the oven after cooking.
However, retrospective and prospective memory are not 
doubly dissociable.19 Carrying out a prospective memory 
task is dependent upon being able to remember informa-
tion about the action to be performed.20 For example, 
remembering to post a letter would require mental repre-
sentations such as location and image of a post box and the 
letter. However, the strength of the relationship between 
retrospective and prospective memory is task dependent. 
Remembering to post a letter may be less dependent upon 
retrospective memory than remembering to buy items 
required for an evening meal, which would require a greater 
number of mental  representations. Attree et al21 previously 
assessed both prospective and retrospective memory in 
eleven women with ME/CFS and 12 healthy women using 
a computer-generated virtual environment. People with 
ME/CFS performed slightly worse than healthy controls 
on prospective memory, although this was not statistically 
significant. However, the ME/CFS group performed signifi-
cantly worse than the healthy controls on both a free recall 
task and a subjective assessment of both retrospective and 
prospective memory.
There is evidence to show that depression is linked 
with cognitive measures (in ME/CFS3 and in multiple 
sclerosis [MS]22) and unsurprisingly, many patients with 
a chronic illness show higher levels of depression than 
healthy people.22 It is also well documented within the 
literature that depressed patients have problems with 
memory and concentration. While the mechanism is 
unclear, Porter et al23 state that changes in cognitive 
function may be mediated by symptom-related factors 
and neurobiological factors, such as hippocampal atrophy 
and hormonal changes in the hypothalamic–pituitary–
adrenal axis.
Diamond et al24 reported that increased levels of fatigue 
and depressed mood were correlated with fewer words 
remembered in short- and long-term memory recall tests in 
people with MS. Bol et al,22 also investigating MS, found 
that anxiety, depression, and mental fatigue contributed to 
cognitive complaints, but not to cognitive performance. 
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Both fatigue and depression then, are likely to influence 
memory scores in people with ME/CFS, and any  differences 
found between groups might be explained – partially at 
least – by fatigue. Since fatigue is so central to ME/CFS, it 
may make a larger contribution to cognitive function than 
in other illnesses where the fatigue is not a central feature 
of the illness. Chaudhuri and Behan5 stated that central 
fatigue may occur due to a failure in the integration of the 
limbic input and the motor functions within the basal gan-
glia affecting the striatal–thalamic–frontal cortical system. 
Nes et al25 stated that the damage to the prefrontal cortex 
causes “deficits in organizing and executing appropriate 
behavior such as impulsivity, perseveration, poor judgment, 
interference with problem-solving, and disinhibition.” 
Executive control (coordinated by the prefrontal cortex) 
is prone to fatigue as this capacity is limited. Nes et al25 
stated that the ability to manage conditions such as ME/
CFS depends on executive function. Supporting evidence 
for this was found by Okada et al,26 who found that ME/
CFS patients had reduced gray matter volume in the bilateral 
prefrontal cortex and that the volume reduction paralleled 
the severity of the fatigue.
Other factors are also likely to be related to fatigue and 
cognitive function, including self-efficacy. General self-
efficacy refers to the confidence individuals have about 
their ability to cope across different situations. It reflects 
the belief that the individual will cope with demands by 
taking adaptive action.27 General self-efficacy28 has been 
shown to be reliable and valid in many studies in numerous 
countries,29 and this scale has been shown to be a universal 
construct which is also related to optimism, self-esteem, and 
depression.30 Low general self-efficacy is associated with 
depression, anxiety, and helplessness31 and has been shown 
both to be a moderator of other variables32,33 and a mediator 
variable.33,34 Arnstein et al34 found that self-efficacy was a 
mediator between pain and depression. Depression, social 
support, and self-efficacy are associated with each other, and 
may act together in influencing cognitive performance; eg, 
there is also some evidence for a relationship between social 
support and cognitive ability.35,36 Desrichard and Köpetz37 
have shown that memory performance and memory-self 
efficacy are positively related, and another study showed 
that memory performance can be increased by self-efficacy 
enhancing interventions.38 Self-efficacy enhancing interven-
tions have been shown to induce positive change in other 
instances such as better walking performance for patients 
with chronic obstructive pulmonary disease39 and quality of 
life for asthma sufferers.40
This study set out to explore the relationships between 
variables which have been found to contribute to cognitive 
performance, as measured by prospective and retrospective 
memory, and cognitive failures. Based on the literature, we 
hypothesized that cognitive performance of participants with 
ME/CFS would be predicted by a combination of factors, 
which included the positive factors of self-efficacy and social 
support and the negative factors of anxiety, depression, and 
fatigue. Furthermore, we predicted that fatigue would be the 
strongest predictor of poor memory and cognitive failures, 
and that general self-efficacy would mediate between fatigue 
(and depression) and cognitive measures.
Methods
study design and participant selection
This study constituted a cross-sectional survey design which 
was approved by the University of East London ethics 
 committee. Potential participants were recruited from an 
existing database of 138 people who had previously expressed 
an interest in taking part in research related to ME/CFS. This 
database is held by the Chronic Illness Research Team in 
password-protected files on university computers only which 
are also protected by a firewall. This is a general database 
in which anyone who is interested in the researchers’ work 
can be included and then contacted with details of future 
studies. To meet the inclusion criteria participants had to have 
a diagnosis of ME/CFS by a qualified medical practitioner, 
be suffering from ME/CFS for at least the past year, and had 
to be over 18 years of age.
Measures
Fatigue (chalder Fatigue scale)
The Chalder Fatigue Scale41 is a self-report questionnaire 
measuring severity of fatigue. Consisting of 14 items, par-
ticipants are asked to think about the last week and to tick 
the box which most closely relates to each question (eg, 
“did you need to rest more?”; “did you have less strength in 
your muscles?”). Answers are on a 4-point scale to choose 
from for each item, “better than usual” to “much worse than 
usual.” This scale illustrates very good internal consistency 
(Cronbach’s alphas =0.88–0.90) and successfully discrimi-
nates between those with and without fatigue.42
Depression (center for epidemiologic  
studies Depression scale)
The Center for Epidemiologic Studies Depression (CES-D) 
scale is self-report measure comprising 20 items designed 
to measure depressive symptoms in the general population.43 
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Participants are asked to rate each item on how often they 
have felt that way in the past week. Answers range from 
“rarely or none of the time” to “all of the time.” The internal 
consistency of the CES-D is good, with reliability analyses 
yielding Cronbach’s alphas of 0.63 to 0.93.43  Temporal stabil-
ity analysis (over a 3-month period) resulted in a correlation 
of 0.61, which is also acceptable.44
anxiety (hospital anxiety and Depression scale)
The Hospital Anxiety and Depression Scale (HADS)45 was 
used to measure anxiety. This is a self-report measure which 
measures participants’ feelings of anxiety or depression over 
the past week. Ratings are on a 1–4 Likert scale. The inter-
nal consistency of the anxiety subscale is good, resulting in 
Cronbach’s alphas of 0.76 to 0.93 in its English versions.46 
Concurrent validity of the anxiety subscale is also good, with 
correlations of 0.69 and 0.75 with the Clinical Anxiety Scale 
and 0.64 to 0.81 with the Spielberger’s State-Trait Anxiety 
Inventory.46
social support (Medical Outcome study)
The Medical Outcome Study (MOS) social support sur-
vey47 is a 19-item scale that was developed for patients with 
chronic conditions. Participants are asked to rate each item 
on a 5-point scale ranging from “none of the time” to “all of 
the time.” Internal consistency for this measure is very good, 
with Cronbach’s alphas of between 0.91–0.97, as is temporal 
stability at 1 year with correlations of between 0.72–0.78. 
Convergent validity is also good, with correlations between 
the MOS and measures of loneliness =−0.67, family function-
ing =0.53, and marital functioning =0.56.47
General self-efficacy scale
Developed by Schwarzer and Jerusalem,28 the general self-
efficacy scale (GSE) is a 10-item measure where participants 
are asked to rate each item by choosing one of four answers 
ranging from “not at all true” to “exactly true.” The GSE 
typically yields high internal consistency coefficients of 
between 0.75–0.91 and test–retest reliability correlations of 
between 0.55–0.75.27
cognitive function
Prospective and retrospective memory  
questionnaire
Smith et al48 developed a scale in order to assess the prospec-
tive and retrospective memory of patients with dementia. 
It is a 16-item scale that asks participants how often each 
item happens to them; eg, “Do you decide to do something 
in a few minutes’ time and then forget to do it?” Answers 
are on a 5-point scale ranging from “never” to “very often.” 
The internal consistency is very good for this scale, with 
Cronbach’s alphas of 0.89 for the total scale, 0.84 for prospec-
tive memory scale, and 0.80 for the retrospective memory 
scale.49 The ability of this measure to predict actual memory 
deficits varies between the two subscales, with the prospec-
tive memory scale illustrating better performance than the 
retrospective scale.50
cognitive Failures questionnaire
The Cognitive Failures questionnaire (CFq)51 is a 25-item 
questionnaire which measures failures of perception, memory, 
and motor function. Participants are asked to rate how often 
they experience each type of error on a 5-point Likert-type 
scale ranging from 0 (“never”) to 4 (“very often”); eg, “do 
you find you confuse right and left when giving directions?” 
The total score for this questionnaire ranges from 0–100 with 
higher scores indicating more types of cognitive failures. 
The construct validity of this measure is good, illustrating 
significant positive correlations with the affective response, 
perception of time, and constraint subscales of the Boredom 
Proneness Scale and the attention and hyperactivity subscales 
of the Adult Behavior Checklist.52 In terms of the question-
naire’s association with actual mishaps (eg, an accident, an 
injury-caused hospitalization, a serious fall), CFq scores 
differed significantly (in the expected direction) between 
participants defined as mishap-involved as compared to those 
defined as mishap-free.53
Procedure
A letter, an information sheet, a consent form, personal details 
form, a prepaid envelope, and the questionnaires described 
above were posted to 138 people on the database. The ques-
tionnaires were packed according to a Latin-square design; 
eg, participant one would receive the Chalder Fatigue Scale 
followed by the CES-D, HADS, MOS, GSE, prospective 
and retrospective memory questionnaire (PRMq), and CFq. 
Participant two would receive the CES-D, HADS, MOS, 
GSE, PRMq, CFq, and the Chalder Fatigue Scale, and so on. 
Participants were instructed to complete the questionnaires in 
the order in which they appeared in the pack. Eighty-seven 
participants (85 women and two men) returned questionnaire 
packs by the 4-week deadline that was given. This represents 
a 63% response rate. No reminders were issued in this study. 
All data was entered manually into SPSS for Windows version 
18.0 (IBM Corporation, Armonk, NY, USA) by two members 
of the research team and cross-checked.
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Results
A total of 87 respondents completed and returned the ques-
tionnaire packs; 85 women (97.7%) and two men (2.3%). 
The mean age of the sample was 54.80 years (standard 
deviation =10.32 years). The data were analyzed using 
SPSS for Windows version 18.0. Pearson’s r correlations and 
 hierarchical multiple regressions were used to demonstrate 
the relationships between the variables.54 Descriptive statis-
tics are shown in Table 1.
We computed full correlations for the psychosocial vari-
ables with cognitive measures (see Table 2). As can be seen 
from Table 2, higher levels of depression and fatigue were 
associated with a worsening of cognitive performance. Social 
support showed no important or significant relationships with 
any of the variables and was therefore excluded from further 
analysis. Pearson’s correlations (one-tailed) were computed 
for the psychosocial variables (see Table 3).
Since the variables were intercorrelated, we chose stan-
dard multiple regression to determine the unique contribution 
of fatigue, general self-efficacy, depression, and anxiety to 
our cognitive measures.
Prospective memory
As noted in the introduction, retrospective and prospective 
memory are not dissociable, although the strength of the 
correlation between these may vary. Retrospective memory 
was entered in the model at step 1 as a covariate. Depression, 
fatigue, self-efficacy, and anxiety were entered at step 2.
As expected, retrospective memory was highly corre-
lated with prospective memory (R=0.868, Adj R2 =0.750; 
F
1,80
=241.365, P,0.001). At step 2, the other predictor 
variables raised the correlation to 0.872 only, and this small 
change was not statistically significant. The final model 
is shown in Table 4. None of the predictor variables, once 
Table 1 Means and standard deviations for each variable
Variable Mean Standard  
deviation
95% confidence 
interval
Lower Upper
age 54.80 10.32 52.31 57.00
Duration of illness 16.67 9.96 14.77 19.24
Fatigue 36.70 7.47 34.99 38.16
social support 61.15 20.52 52.26 65.39
Retrospective memory 21.79 8.56 19.90 23.70
Prospective memory 26.18 8.64 24.24 29.13
cognitive failures 57.37 18.88 52.90 61.45
anxiety 17.42 2.55 16.95 18.07
Depression 21.87 9.80 19.59 24.01
Self-efficacy 26.51 6.12 24.99 27.81
Table 2 Pearson’s r correlations (two-tailed) between the 
psychosocial and cognitive variables
Cognitive  
failures
Prospective  
memory
Retrospective  
memory
Depression 0.479; P,0.001 0.358; P=0.001 0.376; P,0.001
Fatigue 0.388; P,0.001 0.298; P=0.005 0.354; P=0.001
social support 0.030; P=0.791 −0.062; P=0.566 −0.042; P=0.703
general  
self-efficacy
−0.385; P,0.001 −0.277; P=0.009 −0.320; P=0.003
anxiety −0.225; P=0.043 −0.187; P=0.088 −0.259; P=0.018
Table 3 Pearson’s r correlations between the psychosocial 
variables
Fatigue General self-efficacy Anxiety
Depression 0.436;  
P,0.001
−0.456; P,0.001 −0.551; P,0.001
Fatigue −0.138; P=0.101 −0.219; P=0.023
general  
self-efficacy
−0.350; P=0.001
retrospective memory was controlled for, were statistically 
significant. The beta weights show that the lines of best fit 
are virtually flat.
Retrospective memory
The exploratory variables significantly predicted retrospective 
memory (R=0.470, Adj R2 =0.18). The analysis of variance 
(ANOVA) showed that F
4,76
=5.392, P=0.001. The regression 
analysis is shown in Table 5. Here the strongest predictor was 
not depression, but fatigue, which independently and signifi-
cantly predicted scores on retrospective memory.
cognitive failures
The predictor variables significantly predicted cognitive failures 
(R=0.558, Adj R2 =0.27). The ANOVA showed that F
4,75
=8.459, 
P,0.001. The regression analysis is shown in Table 6.
Depression shows the strongest relationship with cognitive 
failures, and in this analysis, only anxiety was nonsignificant. 
Without consideration of the other variables, depression on its 
own relates strongly to all three memory measures. However, it 
is only in the last analysis – cognitive failures – that it becomes 
possible to elucidate the way in which the independent 
variables relate to memory because it is only with cognitive 
failures that the predictors (except for anxiety), contribute 
independently and significantly to cognitive performance.
From the results for all three cognitive measures, it seems 
that depression and fatigue in particular are involved in 
memory problems. It is not easy to determine a causal link 
between these two variables, so that in our path diagram we 
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Table 4 criterion variable = prospective memory. a two-step multiple regression analysis (n=81)
Model Unstandardized 
coefficients (beta)
Standardized 
coefficients (beta)
t P-value 95% confidence  
interval
Lower Upper
1. constant 6.687 5.002 ,0.001 4.03 9.35
Retrospective memory 0.892 0.868 15.536 ,0.001 0.78 1.01
2. constant 2.252 0.383 0.703 −9.46 13.96
Retrospective memory 0.893 0.869 13.570 ,0.001 0.76 1.03
Fatigue −0.065 −0.054 −0.824 0.413 0.22 0.09
General self-efficacy 0.010 0.007 0.105 0.916 −0.17 0.19
Depression 0.090 0.101 1.272 0.207 −0.05 0.23
anxiety 0.261 0.074 1.088 0.280 −0.22 0.74
Notes: step 1 accounts for 75% of the variance; step 2 accounts for a further 6% (adjusted R2 squares).
Table 5 Retrospective memory: standard multiple regression (n=81)
Model Unstandardized 
coefficients (beta)
Standardized 
coefficients (beta)
t P-value 95% confidence  
interval
Lower Upper
constant 15.766 – 1.564 0.122 −4.31 35.84
Fatigue 0.298 0.255 2.221 0.029 0.03 0.57
General self-efficacy −0.277 −0.203 −1.756 0.083 −0.59 0.04
Depression 0.138 0.159 1.127 0.263 −0.11 0.38
anxiety −0.038 −0.011 −0.091 0.927 0.87 0.80
Note: This model accounts for 22% of the variance (adjusted R2).
included them as co-moderators of, and self-efficacy as a 
mediator variable on, cognitive failures. The path coefficients 
are partial, standardized beta weights and therefore can be 
compared directly with each other. The beta weights were 
calculated by performing standard multiple regression analy-
ses within SPSS, a) using fatigue, depression, and general 
self-efficacy as predictor variables, and cognitive failures as 
the criterion variable and b) using fatigue and depression 
as the predictor variables, and general self-efficacy as the 
criterion variable. Both regression analyses were statistically 
significant (R=0.553, F
3,77
=11.30 and R=0.457, F
2,80
=10.576, 
respectively, both P,0.001) (see Figure 1).
However, the direct effect of fatigue on cognitive failures 
(without consideration of other variables) was statistically sig-
nificant (beta =0.228, P =0.037). The indirect effects were not 
statistically significant individually. In the path diagram, with 
all effects included, general self-efficacy is shown to be a partial 
mediator, since the direct and indirect effects together signifi-
cantly predict cognitive functioning (beta =0.389, P,0.001).
Discussion
The proposed model shows that fatigue, depression, and 
general self-efficacy relate directly to cognitive failures. 
Fatigue and depression may be a result of the neurobiological 
effects of ME/CFS. It is well-documented that people with 
chronic illnesses have higher levels of depression, and that 
people with ME/CFS tend to be more depressed than many 
other illness groups. Depression is known to directly affect 
neuropsychological performance, and our study confirmed 
this also. There have been many reasons put forward for 
these findings.55 A lack of general motivation associated with 
depression may lead to a lowering of self-efficacy, which in 
turn, leads to cognitive failures. Fatigue, depression, and self-
efficacy have direct effects on cognitive failures, fatigue being 
positively associated with the number of cognitive failures 
made. This confirms previous research discussed earlier, 
and was expected. Of course, depression itself may have a 
bidirectional relationship with self-efficacy, and certainly 
with fatigue. It is interesting that fatigue had no significant 
relationship to self-efficacy, whereas depression did. Higher 
scores on self-efficacy were associated with a lower number 
of cognitive failures. However, both of the direct effects were 
weak. Despite that, it might be that self-efficacy enhancing 
interventions would produce positive changes in cognitive 
performance, and in other dimensions such as those shown 
in patients with other illnesses.38–40
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Table 6 cognitive failures: standard multiple regression (n=80)
Model Unstandardized 
coefficients (beta)
Standardized 
coefficients (beta)
t P-value 95% confidence 
interval
Lower Upper
constant 13.312 – 1.463 0.148 −11.33 73.95
Fatigue 0.579 0.220 2.030 0.046 0.01 1.147
General self-efficacy −0.727 −0.240 −2.187 0.032 −1.39 −0.07
Depression 0.601 0.311 2.328 0.023 0.087 1.12
anxiety 0.618 0.081 0.701 0.485 −1.14 2.37
Note: This model accounts for 27.4% of the variance (adjusted R2).
Fatigue
General self-efficacy
Depression
Cognitive
failures
0.228; P=0.037
−0.225; P=0.040
0.269; P=0.027
0.040; P=0.717
0.436; P<0.001
−0.473; P<0.001
Figure 1 Path diagram: fatigue, depression, general self-efficacy and their relationship to cognitive failures.
In this study, fatigue appears to affect retrospective 
memory which confirms research from studies on other 
illnesses.24 However, the other psychosocial variables seem 
to have little effect on retrospective memory. It is puzzling 
why the results for retrospective memory were weaker than 
those for cognitive failures. As the explanatory variables 
were correlated with each other and did not independently 
predict prospective and retrospective memory, it is not easy 
to disentangle the relationships between them. However, it 
appears that prospective memory is not affected by fatigue 
or depression, once the retrospective part of prospective 
memory is controlled for. This contradicts the findings of 
previous research by Attree et al,21 although this may be 
explained by the fact that these researchers did not partial 
out retrospective memory scores in their analysis. However, 
it may be because in the current study we have a general 
measure of fatigue. Future studies should measure the differ-
ent aspects of fatigue, as it could be possible that more spe-
cific measures of fatigue (eg, cognitive fatigue) may actually 
have an effect on prospective memory, even if retrospective 
memory is controlled for.
Although it is clear that people with ME/CFS rate both 
their prospective and retrospective memory as worse than 
healthy controls, since the measure is self-reported, we have 
no objective evidence to confirm actual memory performance. 
Findings from studies which have investigated the difference 
between subjective and objective measures of memory in 
this group have been inconclusive.11 Nevertheless, in other 
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patient groups self-reported memory problems appear to be 
related to objective memory assessments.56
There may be several reasons why people with chronic 
 illness perform poorly on tests of memory. For some illnesses, 
such as MS, structural changes in the brain could account for 
poor neuropsychological performance. Both depression and 
fatigue, and also certain centrally-acting medications, can 
account for a worsening of cognitive function. Deficits due 
to these latter causes are common to most chronic illnesses. 
This is supported by a wealth of research showing a range 
of cognitive deficits in illnesses such as inflammatory bowel 
disease and irritable bowel syndrome,57 fibromyalgia,58 
Parkinson’s disease,59 and MS,24 all of which have depression 
and fatigue in common.
The fact that fatigue relates to cognitive failures confirms 
the findings of previous studies. However, what is the mecha-
nism of action here? Wearden and Appleby12 stated that ME/
CFS patients may perform cognitive tasks at a similar level to 
healthy controls, but “only by virtue of diverting extra process-
ing resources to the task, which is perceived as fatiguing.” 
The central fatigue of ME/CFS is not, by definition, simply 
somatic. It is often described by people with ME/CFS as 
“brain fog” – that is, the affected person cannot think properly 
and mental tasks are just as difficult as physical tasks. Interest-
ingly, Bol et al,22 studying people with MS, found that mental 
fatigue, rather than physical fatigue, related to self-reported 
cognitive impairment. If people with ME/CFS are asked to 
perform numerous or complex tasks, which are fatiguing, then 
participants are likely to either perform worse on the tasks, 
and/or become fatigued. Alternately, they may use all their 
resources to do well on the set tasks, but after finishing the 
tasks, their symptoms are likely to worsen and this group of 
people will need to rest more than is usual.
Contrary to expectations and previous research, it appears 
that social support does not contribute to cognitive measures, 
or indeed to the other explanatory variables. This was there-
fore excluded at an early stage of our analyses. Management 
programs which focus on dealing with factors such as self-
efficacy, depression, and symptom expectation may improve 
cognitive function and the quality of life of people with ME/
CFS. It will be interesting to see if this is accompanied by 
improvements in memory.
limitations of the study and future work
Since the participants with ME/CFS were a self-selected 
group, that is, they had previously expressed their desire to 
take part in ME/CFS research, this group may not be repre-
sentative of all people with ME/CFS. Also it was not possible 
in this study to obtain independent verification of diagnosis. 
However, we believe the diagnosis of ME/CFS is likely sound 
given the duration of the symptoms and the absence of an 
alternative diagnosis proffered to patients by their medical 
practitioners. A further limitation is that we did not obtain 
ratings of severity of illness. Future studies will need to 
take these factors into account and also examine changes in 
cognition and memory with the post-exertional malaise that 
typifies ME/CFS. Finally, the response rate could have been 
improved if reminders had been sent to participants and we 
will endeavor to do this in future studies.
Although our model shows that fatigue leads to cognitive 
failures, it may be that the illness itself (which may include 
changes in the hypothalamic–pituitary–adrenal axis, neuroen-
docrine dysregulation, and other neurobiological effects) may 
give rise to both fatigue and cognitive deficits, independently; 
ie, that the correlation between fatigue and cognitive failures 
are both due to a third variable – the neurobiological effects 
of ME/CFS. Therefore, other areas of future work may want 
to focus on these effects and also the pathophysiological 
mechanism(s) of ME/CFS to discover how these relate to 
fatigue and cognitive performance; for instance, various 
studies have reported abnormalities in the immune system, 
including elevated proinflammatory cytokines, which could 
explain fatigue.60 The importance of elevated proinflammatory 
cytokines in the etiology of fatigue is also strongly suggested 
by work in patients with MS with and without fatigue.61 It is 
presently unclear whether the low level increase in inflam-
matory cytokines seen in ME/CFS62 and associated with 
an increase in highly sensitive C-reactive protein, a general 
marker for inflammation and infection,63 can cause significant 
impairment of cognition and memory in individuals with ME/
CFS; this would be a worthwhile area of future study.
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